Segall Bryant & Hamill’s Vaxcyte PCVX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $5.86M | Buy |
180,239
+30,477
| +20% | +$991K | 0.08% | 295 |
|
2025
Q1 | $5.66M | Sell |
149,762
-4,226
| -3% | -$160K | 0.09% | 294 |
|
2024
Q4 | $12.6M | Sell |
153,988
-2,068
| -1% | -$169K | 0.17% | 181 |
|
2024
Q3 | $17.8M | Sell |
156,056
-6,376
| -4% | -$729K | 0.24% | 131 |
|
2024
Q2 | $12.3M | Buy |
162,432
+4,411
| +3% | +$333K | 0.22% | 155 |
|
2024
Q1 | $10.8M | Sell |
158,021
-2,260
| -1% | -$154K | 0.2% | 173 |
|
2023
Q4 | $10.1M | Buy |
+160,281
| New | +$10.1M | 0.19% | 183 |
|